Terms of reference


Final Determinations

1. These Terms of Reference were proposed, following discussion, at the first SIDCER Steering Committee Meeting of 17-18 June 2002 in Chicago, Illinois, USA. The Terms of Reference are presented to the Director of TDR/WHO for approval.

2. Present at the First Steering Committee meeting were representatives of the following fora:

  • Pan-African Bioethics Initiative (PABIN)
  • Foro Latino Americano de Comités de Ética en Investigacion en Salud [Latin American Forum of Ethics Committees in Health Research] (FLACEIS)
  • Forum for Ethics Committees in the Confederation of Independent States (FECCIS)
  • Forum for Institutional Review Boards [IRBs]/Ethical Review Boards [ERBs] in the United States and Canada (FOCUS) [in development]
  • Forum for Ethical Review Committees in Asia & the Western Pacific (FERCAP)

3. The following organizations were proposed to join TDR/WHO with representatives on the Steering Committee

  • United States Department of Health & Human Services (DHHS)
  • European Forum for Good Clinical Practice (EFGCP)
  • International Federation of Pharmaceutical Manufacturers Associations (IFPMA)
  • International Clinical Epidemiology Network (InCLEN)

4. According to Article 9.2., the following members of the Steering Committee were elected to the following positions for a period of three years, ending 31 December 2005:

  • As Steering Committee Chairperson _________________________
  • As Co-Steering Committee Chairperson ______________________
  • As Secretary ______________________________
  • As Treasurer ______________________________
  • As Ethics Officer __________________________
  • As Education Officer _______________________
  • As Communication Officer __________________

5. An appended list of organizations and individuals were proposed to join the SIDCER Advisory Board.

6. The Strategic Initiative for Capacity Building in Ethical Review (SIDCER) held its first Project Development Team meeting in Brussels, Belgium, on 11 May 2001. A 2nd Project Development Team Meeting was held on 19 June 2001 in Geneva, Switzerland. During the 3rd Project Development Team Meeting on 6-8 December 2001 in Bethesda, MD, USA, the general principles of these Terms of Reference were agreed. The draft Terms of Reference were presented for discussion at the 1st SIDCER Project Team meeting held in Brussels, Belgium on 18 & 19 April 2002.

7. These Terms of Reference are binding for all future activities of the Strategic Initiative for Capacity Building in Ethical Review (SIDCER).

8. Appended to these Terms of Reference are the SIDCER Strategic Plan (Appendix I), the SIDCER Steering Committee Description (Appendix II), the SIDCER Operating Budget (Appendix III), and the SIDCER Policy on Funding and Conflict of Interest (Appendix IV) as adopted during the first SIDCER Steering Committee Meeting of 17-18 June 2002 in Chicago, Illinois, USA.

Signatories to These Terms of Reference


For the Fora
Chifumbe Chintu Pan-African Bioethics Initiative (PABIN)
Dafna Feinholz Foro Latino Americano de Comités de Ética en Investigacion en Salud [Latin American Forum of Ethics Committees in Health Research] (FLACEIS)
Olga Kubar Forum for Ethics Committees in the Confederation of Independent States (FECCIS)
Richard Carpentier Forum for Institutional Review Boards [IRBs]/Ethical Review Boards [ERBs] in the United States and Canada (FOCUS) [in development]
Vichai Chokevivat Forum for Ethical Review Committees in Asia & the Western Pacific (FERCAP)
For the Invited Partner Organizations
United States Department of Health & Human Services (DHHS)
Francis P. Crawley European Forum for Good Clinical Practice (EFGCP)
International Federation of Pharmaceutical Manufacturers Associations (IFPMA)
For TDR/WHO
Juntra Karbwang
Robert Ridley
Share